Finanznachrichten31m
DelveInsight Business Research, LLP: 75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight
The FDA recently cleared ABA-101's Investigational New Drug (IND) application, and initiation of a first-in-human (FIH) Phase I study is imminent. In August 2024, TG Therapeutics announced that the ...
Saint Louis University7m
Saint Louis University School of Medicine
The SLU School of Medicine trains physicians and biomedical scientists, conducts medical research and provides local, national and international health services. Beyond the important objective of ...